Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gemcitabine × Classical hematology × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 109 Thoracic 72 Breast 41 Genitourinary 40 Head & Neck 31 Gynecologic 30 Lymphoid 24 Tumor-Agnostic 4 Sarcoma 3 Other solid neoplasm 2 Classical hematology 1

Conditions

Interventions

Epoetin Alfa 25 Darbepoetin alfa 10 Dalteparin 7 Rivaroxaban 6 Cytarabine 6 apixaban 5 Heparin, Low-Molecular-Weight 5 Etoposide 5 emicizumab 4 Tinzaparin 4 Methotrexate 4 Idarubicin 4 Daunorubicin 4 Cyclophosphamide 4 pegfilgrastim 3 Thioguanine 3 Saline Solution 3 Mitoxantrone 3 Hydrocortisone 3 Granulocyte Colony-Stimulating Factor 3 Erythropoietin 3 Enoxaparin 3 Asparaginase 3 oprelvekin 2 luspatercept 2 fludarabine phosphate 2 fludarabine 2 ferric derisomaltose 2 ferric carboxymaltose 2 epoetin beta 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡